Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
R. M. Du Bois (London, United Kingdom). Modifying remodelling and repair in ILD: a new therapeutic approach?. Annual Congress 2006 - PG15 - Remodelling and repair in lung disease

Member's Comments

No comment yet.

Related content which might interest you: Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Source: Eur Respir J 2010; 36: 1232-1235 Year: 2010 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 A novel strategy to counteract airway wall remodelling in asthma: Blocking the neo-vascularisation of the lamina propria Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment Source: Eur Respir J, 52 (4) 1801718; 10.1183/13993003.01718-2018 Year: 2018 A novel strategy to counteract airway wall remodelling in asthma: blocking the neo-vascularisation of the lamina propria Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Interference RNA as a new tool and possible future therapy for inflammatory lung disease Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 The concept of control in COPD: a new proposal for optimising therapy Source: Eur Respir J 2014; 44: 1072-1075 Year: 2014 Chronic lung diseases: prospects for regeneration and repair Source: Eur Respir Rev, 30 (159) 200213; 10.1183/16000617.0213-2020 Year: 2021 Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016 Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction? Source: Eur Respir J 2007; 30: 821-822 Year: 2007 Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise? Source: Eur Respir J 2007; 29: 229-230 Year: 2007 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 N-ethyl-N-nitrosourea mutagenesis: a new tool for exploring lung disease Source: Annual Congress 2010 - Scientific Year in Review Year: 2010